US 10101331
Methods of evaluating patients using E-cadherin or vimentin
granted A61KA61K31/433A61K38/50
Quick answer
US patent 10101331 (Methods of evaluating patients using E-cadherin or vimentin) held by Agios Pharmaceuticals, Inc. expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/433, A61K38/50